FRANKLIN LAKES, N.J., May 15, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained. The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a reta ...

New Jersey 22-0760120 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) | --- | --- | --- | |-------------------------|-------|-------------------------------| | | | | | Large accelerated filer | ☒ | Accelerated filer | | Non-accelerated filer | ☐ | Smaller reporting company | | Emerging growth company | ☐ | | TABLE OF CONTENTS | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------------------------|-------|-- ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...

Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer, and Head of Investor Relations Tom Polen - Chairman, Chief Executive Officer, and President Chris DelOrefice - Executive Vice President, and Chief Financial Officer Mike Garrison - President of the Medical Segment Dave Hickey - President of the Life Sciences Segment Rick Byrd - President of the Interventional Segment Conference Call Participan ...

For the quarter ended March 2024, Becton Dickinson (BDX) reported revenue of $5.05 billion, up 4.7% over the same period last year. EPS came in at $3.17, compared to $2.86 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.03 billion, representing a surprise of +0.30%. The company delivered an EPS surprise of +7.09%, with the consensus EPS estimate being $2.96.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Becton, Dickinson and Company (BDX) , popularly known as BD, delivered adjusted earnings per share (EPS) of $3.17 in the second quarter of fiscal 2024, up 10.8% year over year. The figure topped the Zacks Consensus Estimate by 7.1%.The adjustments include expenses related to purchase accounting adjustments and integration costs, among others.GAAP EPS for the quarter was $1.85, reflecting an improvement of 20.9% from the year-earlier figure.Revenues in DetailBD registered revenues of $5.05 billion in the fis ...

Becton Dickinson (BDX) came out with quarterly earnings of $3.17 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.86 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.09%. A quarter ago, it was expected that this medical device manufacturer would post earnings of $2.39 per share when it actually produced earnings of $2.68, delivering a surprise of 12.13%.Over the last four qua ...

| --- | --- | --- | --- | |---------------------|-----------------------|----------------------------------|-------| | | | | | | | | | | | | | | | | Q2 FY24 May 2, 2024 | Earnings Presentation | | | | | | | | | | | Advancing the world of health ™ | | Caution Concerning Forward-Looking Statements This presentation and accompanying audio webcast contain estimates and other forward-looking statements (as defined under federal securities laws) reqarding BD's futue pro performance, including, but not limited to, ...

BD Reports Second Quarter Fiscal 2024 Financial Results • Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic • Q2 GAAP and adjusted diluted EPS of $1.85 and $3.17 grew 20.9% and 10.8%, respectively • Year-to-date Cash from Continuing Operations of $1.4 billion and Free Cash Flow of $1.1 billion increased $785 million and over $900 million, respectively • Company raises full-year adjusted EPS guidance and affirms organic revenue growth guidance "Second quarter perfo ...

FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.About BDBD is one of ...